Factors influencing global antiretroviral procurement prices

BMC Public Health

Table 3 Factors influencing purchases higher than the lowest and the highest direct manufactured costs

	More than lowest direct manufactured costs				More than highest direct manufactured costs
	Odds ratio	p-value	Lower 95%CI	Upper 95%CI	Odds ratio	p-value	Lower 95% CI	Upper 95% CI
HIV prevelence < 2%	1				1
HIV Prevelence 2-5%	0.75	0.174	0.50	1.13	1.17	0.389	0.81	1.70
HIV Prevalence >5%	0.86	0.300	0.65	1.14	1.36	0.103	0.94	1.97
Low income	1				1
Lower-middle income	1.43	0.079	0.96	2.14	1.63	0.010	1.13	2.37
Upper-middle income	4.05	0.000	2.23	7.34	2.02	0.003	1.27	3.23
PI*	0.99	0.311	0.98	1.00	0.99	0.480	0.98	1.00
Volume 1 ^st tercile	1				1
Volume 2 ^nd tercile	0.76	0.211	0.50	1.17	1.28	0.060	0.99	1.65
Volume 3 ^th tercile	0.56	0.016	0.35	0.90	0.69	0.055	0.48	1.01
Innovator	4.01	0.003	1.60	10.45	6.10	0.000	3.09	12.05
CHAI**	0.77	0.255	0.49	1.20	0.53	0.001	0.36	0.77
PEPFAR***	0.88	0.482	0.61	1.26	1.27	0.143	0.92	1.75
Pseudo R²	0.0994				0.1752
Number of obs	9161				9161

*API = AIDS Program Effort Index; **CHAI = Clinton Foundation HIV/AIDS Initiative; ***PEPFAR = President's Emergency Plan for AIDS Relief.
Data source: Global Price Reporting Mechanism 2005 to 2008

ISSN: 1471-2458